We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+8.07%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$758M
AUM Growth
+$22.5M
Cap. Flow
-$17.3M
Cap. Flow %
-2.28%
Top 10 Hldgs %
18.02%
Holding
407
New
54
Increased
79
Reduced
159
Closed
52

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$10.3M
2
AAPL icon
Apple
AAPL
+$4.92M
3
SLB icon
SLB Ltd
SLB
+$4.3M
4
AMZN icon
Amazon
AMZN
+$4.1M
5
GILD icon
Gilead Sciences
GILD
+$4.08M

Sector Composition

Rank Sector Weight
1 Technology 22.71%
2 Healthcare 16.05%
3 Industrials 14.18%
4 Consumer Discretionary 11.88%
5 Financials 10.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SWN
201
DELISTED
Southwestern Energy Company
SWN
$1.17M 0.15%
+209,387
New +$1.22M
CBSH icon
202
Commerce Bancshares
CBSH
$8.56B
$1.16M 0.15%
30,641
-1
-0% -$37
ITI
203
DELISTED
Iteris, Inc.
ITI
$1.15M 0.15%
165,424
+22,627
+16% +$154K
RUN icon
204
Sunrun
RUN
$2.37B
$1.15M 0.15%
194,411
-555
-0.3% -$3.19K
RRC icon
205
Range Resources
RRC
$9.39B
$1.12M 0.15%
65,697
+39,578
+152% +$712K
MWA icon
206
Mueller Water Products
MWA
$4.09B
$1.09M 0.14%
86,654
-421
-0.5% -$5.19K
TPIC
207
DELISTED
TPI Composites
TPIC
$1.08M 0.14%
52,956
-257
-0.5% -$5.38K
RADA
208
DELISTED
Rada Electronic Industries Ltd
RADA
$1.07M 0.14%
348,403
+203,851
+141% +$666K
SAGE
209
DELISTED
Sage Therapeutics
SAGE
$1.06M 0.14%
6,431
-395
-6% -$38.3K
BMRN icon
210
BioMarin Pharmaceuticals
BMRN
$13.6B
$1.05M 0.14%
11,784
+2,663
+29% +$232K
PWR icon
211
Quanta Services
PWR
$102B
$1.04M 0.14%
26,672
WAB icon
212
Wabtec
WAB
$49.9B
$1.04M 0.14%
12,789
+3,096
+32% +$237K
STDY
213
DELISTED
SteadyMed Ltd
STDY
$1.02M 0.13%
275,764
+247,343
+870% +$799K
BMI icon
214
Badger Meter
BMI
$3.91B
$997K 0.13%
20,865
-95
-0.5% -$4.4K
ITRI icon
215
Itron
ITRI
$4.49B
$988K 0.13%
14,489
-71
-0.5% -$5.08K
ST icon
216
Sensata Technologies
ST
$6.72B
$985K 0.13%
19,275
-106
-0.5% -$5.22K
TPVG icon
217
TriplePoint Venture Growth BDC
TPVG
$220M
$950K 0.13%
74,828
-81
-0.1% -$1.09K
JKS
218
JinkoSolar
JKS
$860M
$938K 0.12%
39,017
DHR icon
219
Danaher
DHR
$145B
$928K 0.12%
11,280
GLNG icon
220
Golar LNG
GLNG
$5.2B
$919K 0.12%
30,824
MYOK
221
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$905K 0.12%
21,505
-8,393
-28% -$323K
OCLR
222
DELISTED
Oclaro Inc.
OCLR
$895K 0.12%
132,830
-204,822
-61% -$1.51M
PFE icon
223
Pfizer
PFE
$150B
$893K 0.12%
25,984
+5,733
+28% +$195K
CYTK icon
224
Cytokinetics
CYTK
$10.5B
$878K 0.12%
107,728
+28,970
+37% +$329K
HQY icon
225
HealthEquity
HQY
$8.82B
$877K 0.12%
+18,792
New +$930K

Similar funds

Essex Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Essex Investment Management held 407 positions worth $758M, up 3.1% from $736M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Essex Investment Management's Q4 2017 filing shows 54 new, 79 increased, 159 reduced and 52 closed positions. Its largest new stake was RSP Permian, Inc.: 132,375 shares worth $5.38M. The largest sale was Celgene Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Essex Investment Management's largest Q4 2017 buy was RSP Permian, Inc.: 132,375 shares worth $5.38M.
  • Essex Investment Management added most to Illumina in Q4 2017, an estimated $4.92M increase.
  • Essex Investment Management's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.3M.
  • Essex Investment Management fully exited SLB Ltd in Q4 2017, selling an estimated $4.3M.
  • Essex Investment Management's ten largest holdings make up 18% of its $758M portfolio in Q4 2017.
  • Essex Investment Management opened 54 new positions and closed 52 in Q4 2017.
  • Essex Investment Management's portfolio value rose 3.1% quarter-over-quarter to $758M.

Based on Essex Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.